Pharvaris executive sells shares, exercises options
Pharvaris N.V. executive Anne Lesage, Chief Early Development, reported a mix of stock option exercises and open-market sales in Pharvaris common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Pharvaris N.V. executive Anne Lesage, Chief Early Development, reported a mix of stock option exercises and open-market sales in Pharvaris common stock. Over two days, she exercised 25,400 shares through stock options at exercise prices of $8.05 and $2.59 per share and sold 48,300 shares in open-market transactions under a pre-arranged Rule 10b5-1 trading plan.
Following these transactions, the filing shows Lesage holding 56,450 Pharvaris common shares directly and 133,969 shares indirectly through GrayMatters Consulting B.V., an entity she controls. Remaining stock options include 82,000 options with an $8.05 exercise price and 9,072 options with a $2.59 exercise price.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
11 txns
Insider
Lesage Anne
Role
Chief Early Development
Sold
48,300 shs ($1.46M)
Approx. gross sale proceeds
$1.46M
Approx. exercise cost
$164K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 3,700 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 18,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,700 | $2.59 | $10K |
| Sale | Common Stock | 3,700 | $30.2558 | $112K |
| Exercise | Common Stock | 18,000 | $8.05 | $145K |
| Sale | Common Stock | 18,000 | $30.2558 | $545K |
| Sale | Common Stock | 19,200 | $30.2557 | $581K |
| Exercise | Stock Option (Right to Buy) | 3,700 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,700 | $2.59 | $10K |
| Sale | Common Stock | 3,700 | $30.0758 | $111K |
| Sale | Common Stock | 3,700 | $30.062 | $111K |
Holdings After Transaction:
Stock Option (Right to Buy) — 91,072 contracts (Direct);
Common Stock — 56,450 shares (Direct);
Common Stock — 133,969 shares (Indirect, By GrayMatters Consulting BV)
Footnotes (7)
- F1. This is a scheduled exercise and sale from 10b5-1 trading plan.
- F2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. This is a scheduled sale from 10b5-1 trading plan.
- F4. GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
- F5. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F6. 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F7. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
Key Figures
Shares sold: 48,300 shares
Options exercised: 25,400 shares
Sale price example: $30.2557/share
+4 more
7 metrics
Shares sold
48,300 shares
Total Pharvaris common shares sold in open-market transactions
Options exercised
25,400 shares
Total shares acquired via stock option exercises
Sale price example
$30.2557/share
Weighted-average sale price for 19,200-share transaction on April 30, 2026
Direct holdings after trades
56,450 shares
Pharvaris common shares held directly following transactions
Indirect holdings after trades
133,969 shares
Common shares held indirectly via GrayMatters Consulting B.V.
Remaining options at $8.05
82,000 options
Stock options with $8.05 exercise price expiring in 2033
Remaining options at $2.59
9,072 options
Stock options with $2.59 exercise price expiring in 2030
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Stock Option (Right to Buy), restricted stock units, +1 more
5 terms
Rule 10b5-1 trading plan financial
"The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan."
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for derivative transactions exercising into common stock."
restricted stock units financial
"The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect ownership financial
"direct_or_indirect: "I" and nature_of_ownership: "By GrayMatters Consulting BV" indicate indirect ownership of common stock."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Pharvaris (PHVS) executive Anne Lesage report in this Form 4?
Anne Lesage reported exercising Pharvaris stock options and selling common shares. She exercised 25,400 shares at strike prices of $8.05 and $2.59 and sold 48,300 shares in open-market transactions executed under a pre-arranged Rule 10b5-1 trading plan.
What stock options did Anne Lesage exercise in Pharvaris (PHVS)?
She exercised options covering 25,400 Pharvaris common shares. These consisted of grants with exercise prices of $8.05 and $2.59 per share, with vesting schedules where 25% vested on specific dates and the remainder vests in monthly installments over 48 months.
What Pharvaris (PHVS) stock options does Anne Lesage still hold?
Post-transaction, the filing shows remaining options for 82,000 shares with an $8.05 exercise price expiring in 2033 and 9,072 options with a $2.59 exercise price expiring in 2030, reflecting continuing equity-based compensation exposure to Pharvaris.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates